£1 million has been awarded to UCLH Charity from the Wolfson Foundation for research facilities in the new University College Hospital Grafton Way Building which is opening soon.
A new risk-stratification tool which can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19 has been developed by researchers.
UCLH has begun recruiting participants to a trial looking at whether two antiviral drugs given to people who have tested positive for Covid-19 can stop the virus replicating.
UCLH has welcomed the news that the Oxford-AstraZeneca coronavirus vaccine – which UCLH played a significant role in trialling – has today been approved for use in the UK.
UCLH researchers have recruited the first participant in the world to a study testing a long-acting antibody combination treatment to protect against Covid-19.
9 out of 10 people who have had mild or asymptomatic Covid-19 carry neutralizing antibodies 16-18 weeks after infection.
Men are almost three times as likely as women to be admitted to intensive care and have 40% higher odds of dying from Covid-19, according to a new study led by researchers at UCL, Great Ormond Street Hospital and the University of Cape Town.
Neuroscientists at UCL and UCLH have found no significant association between Covid-19 and the potentially paralysing and sometimes fatal neurological condition Guillain-Barré syndrome.
Cutting-edge research aimed at increasing adult hearing aid use could make a dramatic change to people with hearing loss.
New guidance on public involvement in lab-based research has been published by the UCLH BRC, Alzheimer’s Society and Parkinson’s UK, in partnership with patients and researchers.
Cancer and cancer treatment are both independent risk factors for mortality following Covid-19 infection, according to UCLH led research which highlights the ongoing need to protect cancer patients during the pandemic.
The Nursing Team at the NIHR UCLH Clinical Research Facility (CRF) have won the Contribution to World Class Research Award at the 2020 UCLH Celebrating Excellence Awards.
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its ‘Phase 3’ trials which involved UCLH that show its candidate vaccine is effective at preventing COVID-19 and offers a high level of protection.
The team at UCLH, UCL and Mercedes HPP that developed a life-saving breathing device at the height of the pandemic has been shortlisted for the 2020 HSJ Award for Acute Innovation of the Year.
More ‘Generation Z’ boys and girls in the UK are dieting to lose weight than in previous generations, and are likely to overestimate their own weight, finds a new UCL-led study.